Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Equipe Genetique des Anomalies du Developpement, |
RCV001582411 | SCV001994806 | pathogenic | Neurodevelopmental disorder with hypotonia and dysmorphic facies | 2021-10-28 | criteria provided, single submitter | clinical testing | |
3billion, |
RCV001582411 | SCV002058664 | pathogenic | Neurodevelopmental disorder with hypotonia and dysmorphic facies | 2022-01-03 | criteria provided, single submitter | clinical testing | The variant has been observed in at least two similarly affected unrelated individuals (PMID: 34183358, PS4_M). The variant has been previously reported as de novo in a similarly affected individual (PMID: 34183358, PS2_S). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.639, PP3_P). A missense variant is a common mechanism associated with Neurodevelopmental disorder with hypotonia and dysmorphic facies (PP2_P). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000032, PM2_M).Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Institute for Medical Genetics and Human Genetics, |
RCV001582411 | SCV002574827 | likely pathogenic | Neurodevelopmental disorder with hypotonia and dysmorphic facies | 2022-09-22 | criteria provided, single submitter | clinical testing | |
Hudson |
RCV001582411 | SCV004801373 | likely pathogenic | Neurodevelopmental disorder with hypotonia and dysmorphic facies | 2024-03-14 | criteria provided, single submitter | research | |
OMIM | RCV001582411 | SCV001821514 | pathogenic | Neurodevelopmental disorder with hypotonia and dysmorphic facies | 2022-04-25 | no assertion criteria provided | literature only |